Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/35285592/ below:

Considerations to increase rates of breast cancer screening across populations

• PMID: 35285592
• DOI: 10.37765/ajmc.2022.88855

Item in Clipboard

Debra Patt et al. Am J Manag Care. 2022 Apr.

• PMID: 35285592
• DOI: 10.37765/ajmc.2022.88855

Item in Clipboard

Objectives: COVID-19 has caused considerable drops in utilization of breast cancer screening services during the pandemic, especially among certain racial and ethnic groups. Members of the Community Oncology Alliance (COA)-including the COA president, South Carolina oncologist Kashyap Patel, MD-have reported increases in patients, particularly those of color, presenting with stage III and IV cancer at diagnosis. According to data released by the Biden administration, more than 9.5 million recommended cancer screenings had been missed in the United States as a result of the COVID-19 pandemic, as of February 2022. President Joe Biden and First Lady Jill Biden, EdD, aim to address this in the 2022 revitalized Cancer Moonshot Initiative. The findings made by COA as well as by Avalere also suggest that the pandemic has exacerbated existing health care disparities.

Methods: Using a multipayer database, we analyzed breast cancer screening rates for 2 periods-March 1 to September 30, 2019, and March 1 to September 30, 2020-among Medicare fee-for-service (FFS), managed Medicaid, and commercial insurance beneficiaries to understand the potential impact of the COVID-19 pandemic on adherence to the US Preventive Services Task Force breast cancer screening recommendations, which are currently undergoing review. Screening rates were evaluated across 5 racial/ethnic groups and by payer type.

Results: Mean monthly mammogram screening rates among eligible White Medicare FFS beneficiaries dropped to 0.6% in April 2020, but these screening rates recovered to 6.5% by June 2020. Screening rates for eligible Black Medicare FFS beneficiaries recovered on a pace slightly slower than that of White beneficiaries, but more rapidly than that of other groups. By comparison, American Indian/Alaska Native beneficiaries had a mean monthly screening rate of 0.5% in April 2020, which recovered to 3.1% in June 2020; these were below 2019 screening rates of 4.2% for April and 3.9% for June. Differences in screening rates by payer type were also observed. Patients with commercial insurance had higher screening rates compared with those covered by Medicare FFS and managed Medicaid.

Conclusions: Our principal finding shows that mean breast cancer screening rates decreased in April 2020 across all payers, but recovery to prepandemic screening levels has occurred more slowly among certain racial and ethnic minority groups. Differences in recovery rates by payer type highlight a strong relationship between income level and screening utilization.

PubMed Disclaimer

• Race and Ethnicity and Diffusion of Telemedicine in Medicaid for Schizophrenia Care After Onset of the COVID-19 Pandemic.

  Normand SL, Leckman-Westin E, Finnerty M, Jeong J, Tsuei J, Zelevinsky K, Chen Q, Horvitz-Lennon M. Normand SL, et al. JAMA Netw Open. 2025 Jan 2;8(1):e2454776. doi: 10.1001/jamanetworkopen.2024.54776. JAMA Netw Open. 2025. PMID: 39820692 Free PMC article.

• Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic.

  Nguyen T, Ziedan E, Simon K, Miles J, Crystal S, Samples H, Gupta S. Nguyen T, et al. JAMA Netw Open. 2022 Jun 1;5(6):e2214765. doi: 10.1001/jamanetworkopen.2022.14765. JAMA Netw Open. 2022. PMID: 35648400 Free PMC article.

• Racial and Ethnic Disparities in Hospitalization Outcomes Among Medicare Beneficiaries During the COVID-19 Pandemic.

  Song Z, Zhang X, Patterson LJ, Barnes CL, Haas DA. Song Z, et al. JAMA Health Forum. 2021 Dec 23;2(12):e214223. doi: 10.1001/jamahealthforum.2021.4223. eCollection 2021 Dec. JAMA Health Forum. 2021. PMID: 35977303 Free PMC article.

• Barriers to breast cancer screening are worsened amidst COVID-19 pandemic: A review.

  Tsapatsaris A, Babagbemi K, Reichman MB. Tsapatsaris A, et al. Clin Imaging. 2022 Feb;82:224-227. doi: 10.1016/j.clinimag.2021.11.025. Epub 2021 Dec 7. Clin Imaging. 2022. PMID: 34896935 Free PMC article. Review.

• Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis.

  Ng JS, Hamilton DG. Ng JS, et al. J Med Screen. 2022 Dec;29(4):209-218. doi: 10.1177/09691413221101807. Epub 2022 May 20. J Med Screen. 2022. PMID: 35593115 Free PMC article. Review.

• Breast cancer screening during the COVID-19 pandemic: moving from disparities to health equity.

  Richman I, Tessier-Sherman B, Galusha D, Oladele CR, Wang K. Richman I, et al. J Natl Cancer Inst. 2023 Feb 8;115(2):139-145. doi: 10.1093/jnci/djac172. J Natl Cancer Inst. 2023. PMID: 36069622 Free PMC article.

• Impact of COVID-19 pandemic on breast cancer screening in a large midwestern United States academic medical center.

  Johnson KJ, O'Connell CP, Waken RJ, Barnes JM. Johnson KJ, et al. PLoS One. 2024 May 20;19(5):e0303280. doi: 10.1371/journal.pone.0303280. eCollection 2024. PLoS One. 2024. PMID: 38768115 Free PMC article.

• Trends in breast cancer screening during the COVID-19 pandemic within a universally insured health system in the United States, 2017-2022.

  Mani V, Banaag A, Munigala S, Umoh A, Schoenfeld AJ, Coles CL, Koehlmoos TP. Mani V, et al. Cancer Med. 2023 Sep;12(18):19126-19136. doi: 10.1002/cam4.6487. Epub 2023 Aug 28. Cancer Med. 2023. PMID: 37641528 Free PMC article.

• A systematic review of the impact of the COVID-19 pandemic on breast cancer screening and diagnosis.

  Li T, Nickel B, Ngo P, McFadden K, Brennan M, Marinovich ML, Houssami N. Li T, et al. Breast. 2023 Feb;67:78-88. doi: 10.1016/j.breast.2023.01.001. Epub 2023 Jan 5. Breast. 2023. PMID: 36646004 Free PMC article. Review.

• COVID-19 pandemic impact on the potential exacerbation of screening mammography disparities: A population-based study in Ontario, Canada.

  Fu R, Tinmouth J, Li Q, Dare A, Hallet J, Coburn N, Lapointe-Shaw L, Look Hong NJ, Karam I, Rabeneck L, Krzyzanowska M, Sutradhar R, Eskander A. Fu R, et al. Prev Med Rep. 2023 Dec 25;37:102578. doi: 10.1016/j.pmedr.2023.102578. eCollection 2024 Jan. Prev Med Rep. 2023. PMID: 38222304 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3